Skip to content
  • Clinical Studies
  • Pharma SOP’s
  • Pharma tips
  • Pharma Books
  • Stability Studies
  • Schedule M

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • GMP Failures & Pharma Compliance
    • Common GMP Failures
    • GMP Documentation & Records Failures
    • Cleaning & Sanitation Failures in GMP Audits
    • HVAC, Environmental Monitoring & Cross-Contamination Risks
  • Toggle search form

Tag: GMP compliance for biopharmaceuticals

How to Use Risk-Based Approaches for GMP Compliance in the EU

Posted on February 13, 2025 By digi

How to Use Risk-Based Approaches for GMP Compliance in the EU Practical Tips for Implementing Risk-Based Approaches to GMP Compliance in the EU Introduction to Risk-Based Approaches in GMP Compliance Maintaining Good Manufacturing Practices (GMP) compliance is a cornerstone of pharmaceutical manufacturing in the European Union (EU). The European Medicines Agency (EMA) encourages manufacturers to…

Read More “How to Use Risk-Based Approaches for GMP Compliance in the EU” »

GMP in Europe (EMA, MHRA)

How to Implement CAPA for GMP Compliance in Emerging Markets

Posted on February 13, 2025 By digi

How to Implement CAPA for GMP Compliance in Emerging Markets A Step-by-Step Guide to Implementing CAPA for GMP Compliance in Emerging Markets Introduction to CAPA and GMP Compliance Corrective and Preventive Action (CAPA) is an essential component of Good Manufacturing Practices (GMP) in pharmaceutical manufacturing. CAPA ensures that non-conformities are addressed effectively, and measures are…

Read More “How to Implement CAPA for GMP Compliance in Emerging Markets” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India

Posted on February 13, 2025 By digi

How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India Expert Insights on Testing and Releasing Pharmaceutical Products Under Schedule M Revised Introduction to Testing and Release Requirements Under Schedule M Revised Pharmaceutical manufacturing demands rigorous quality checks to ensure that products meet safety, efficacy, and compliance standards. The Schedule M…

Read More “How Schedule M Revised Impacts the Testing and Release of Pharmaceutical Products in India” »

GMP in India

Best Tools for Monitoring GMP Compliance in European Pharmaceutical Facilities

Posted on February 13, 2025 By digi

Best Tools for Monitoring GMP Compliance in European Pharmaceutical Facilities Top Tools to Ensure GMP Compliance in European Pharma Facilities Introduction to GMP Monitoring Tools Compliance with Good Manufacturing Practices (GMP) is essential for ensuring the safety, efficacy, and quality of pharmaceutical products in Europe. The European Medicines Agency (EMA) mandates strict adherence to GMP…

Read More “Best Tools for Monitoring GMP Compliance in European Pharmaceutical Facilities” »

GMP in Europe (EMA, MHRA)

The Impact of GMP on Pharmaceutical Product Stability in Emerging Markets

Posted on February 13, 2025 By digi

The Impact of GMP on Pharmaceutical Product Stability in Emerging Markets Exploring the Role of GMP in Ensuring Pharmaceutical Product Stability in Emerging Markets Introduction to GMP and Product Stability Ensuring pharmaceutical product stability is a critical aspect of drug manufacturing, directly affecting product quality, safety, and efficacy throughout its shelf life. In emerging markets…

Read More “The Impact of GMP on Pharmaceutical Product Stability in Emerging Markets” »

GMP in Emerging Markets (GCC, Latin America, Africa)

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance

Posted on February 12, 2025 By digi

The Importance of Validating Processes and Procedures for Schedule M Revised Compliance Why Validating Processes and Procedures is Crucial for Schedule M Revised Compliance Introduction to Process Validation and Schedule M Revised In pharmaceutical manufacturing, the validation of processes and procedures is critical for ensuring consistent product quality and compliance with regulatory standards. The revised…

Read More “The Importance of Validating Processes and Procedures for Schedule M Revised Compliance” »

GMP in India

How to Achieve Compliance with GMP in Europe for New Drug Introductions

Posted on February 12, 2025 By digi

How to Achieve Compliance with GMP in Europe for New Drug Introductions Step-by-Step Guide to Ensuring GMP Compliance for New Drug Introductions in Europe Introduction to GMP Compliance for New Drugs Launching a new drug in Europe involves navigating a complex regulatory framework, with Good Manufacturing Practices (GMP) being a critical requirement. The European Medicines…

Read More “How to Achieve Compliance with GMP in Europe for New Drug Introductions” »

GMP in Europe (EMA, MHRA)

How to Integrate Environmental Control into GMP in Latin American Facilities

Posted on February 12, 2025 By digi

How to Integrate Environmental Control into GMP in Latin American Facilities A Step-by-Step Guide to Integrating Environmental Control in GMP Facilities in Latin America Introduction to Environmental Control in GMP Facilities Maintaining strict environmental control is a cornerstone of Good Manufacturing Practices (GMP). In pharmaceutical manufacturing, environmental factors such as temperature, humidity, air quality, and…

Read More “How to Integrate Environmental Control into GMP in Latin American Facilities” »

GMP in Emerging Markets (GCC, Latin America, Africa)

How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports

Posted on February 12, 2025 By digi

How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports A Step-by-Step Guide to Achieving Schedule M Revised Compliance for Pharmaceutical Exports Introduction to Schedule M Revised and Pharmaceutical Exports With the globalization of the pharmaceutical industry, ensuring compliance with international quality standards has become essential for manufacturers aiming to export their products. Schedule…

Read More “How to Ensure Compliance with Schedule M Revised for Pharmaceutical Exports” »

GMP in India

How EMA’s GMP Guidelines Support High-Risk Drug Manufacturing

Posted on February 12, 2025 By digi

How EMA’s GMP Guidelines Support High-Risk Drug Manufacturing The Role of EMA’s GMP Guidelines in High-Risk Drug Manufacturing Introduction to High-Risk Drug Manufacturing and GMP Manufacturing high-risk drugs, such as oncology medications, biologics, and advanced therapies, involves complex processes and stringent requirements to ensure safety and efficacy. The European Medicines Agency (EMA) enforces Good Manufacturing…

Read More “How EMA’s GMP Guidelines Support High-Risk Drug Manufacturing” »

GMP in Europe (EMA, MHRA)

Posts pagination

Previous 1 … 8 9 10 … 26 Next

Quick Guide

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • International GMP Inspection Standards and Harmonization
    • Global GMP Inspection Frameworks
    • WHO Prequalification and Inspection Systems
    • US FDA GMP Inspection Programs
    • EMA and EU GMP Inspection Practices
    • PIC/S Role in Harmonized Inspections
    • Country-Specific Inspection Standards (e.g., UK MHRA, US FDA, TGA)
  • GMP Blog

Latest Posts

  • GMP-cGMP Regulations & Global Standards
    • FDA cGMP Regulations for Drugs & Biologics
    • cGMP Requirements for Pharmaceutical Manufacturers
    • ICH Q7 and API GMP Expectations
    • Global & ISO-Based GMP Standards
    • GMP for Medical Devices & Combination Products
    • GMP for Pharmacies & Hospital Pharmacy Settings
  • Applied GMP in Pharma Manufacturing & Operations
    • GMP for Pharmaceutical Drug Product Manufacturing
    • GMP for Biotech & Biologics Manufacturing
    • GMP Documentation
    • GMP Compliance
    • GMP for APIs & Bulk Drugs
    • GMP Training
  • Computer System Validation (CSV) & GxP Computerized Systems
    • CSV Fundamentals in Pharma & Biotech
    • FDA CSV Guidance & 21 CFR Part 11 Alignment
    • GAMP 5 & Risk-Based Validation Approaches
    • CSV in Pharmaceutical & GxP Industries (Use-Cases & System Types)
    • CSV Documentation
    • CSV for Regulated Equipment & Embedded Systems
  • Data Integrity & 21 CFR Part 11 Compliance
    • Data Integrity Principles in cGMP Environments
    • FDA Data Integrity Guidance & Expectations
    • 21 CFR Part 11 – Electronic Records & Signatures
    • Data Integrity in GxP Computerized Systems
    • Data Integrity Audits
  • Pharma GMP & Good Manufacturing Practice
    • FDA 483, Warning Letters & GMP Inspections
    • Data Integrity, ALCOA+ & Part 11 / Annex 11
    • Process Validation, CPV & Cleaning Validation
    • Contamination Control & Annex 1
    • PQS / QMS / Deviations / CAPA / OOS–OOT
    • Documentation, Batch Records & GDP
    • Sterility, Microbiology & Utilities
    • CSV, GAMP 5 & Automation
    • Dosage-Form–Specific GMP (Solids, Liquids, Sterile, Topicals)
    • Supply Chain, Warehousing, Cold Chain & GDP
Widget Image
  • Never Assign Batch Release Responsibilities to Non-QA Personnel in GMP

    Never Assign Batch Release Responsibilities… Read more

  • Manufacturing & Batch Control
    • GMP manufacturing process control
    • Batch Manufacturing record requirements
    • Master Batch record template for pharmaceuticals
    • In Process control checks in tablet manufacturing
    • Line clearance procedure before batch start
    • Batch reconciliation in pharmaceutical manufacturing
    • Yield reconciliation GMP guidelines
    • Segregation of different strength products GMP
    • GMP controls for high potency products
    • Cross Contamination prevention in manufacturing
    • Line clearance checklist for production
    • Batch documentation review before qa release
    • Process parameters control limits in pharma
    • Equipment changeover procedure GMP
    • Batch manufacturing deviation handling
    • GMP expectations for batch release
    • In Process sampling plan for tablets
    • Visual inspection of dosage forms GMP requirements
    • In Process checks for filled vials
    • Startup and Shutdown procedure for manufacturing line
    • GMP requirements for blending and mixing operations
    • Process Control strategy in pharmaceutical manufacturing
    • Uniformity of dosage units in process controls
    • GMP checklist for oral solid dosage manufacturing
    • Process Control
    • Batch Documentation
    • Master Batch Records
    • In-Process Controls
    • Line Clearance
    • Yield & Reconciliation
    • Segregation & Mix-Ups
    • High Potency Products
    • Cross Contamination Control
    • Line Clearance
    • Batch Review
    • Process Parameters
    • Equipment Changeover
    • Deviations
    • Batch Release
    • In-Process Sampling
    • Visual Inspection
    • In-Process Checks for Vials
    • Start-Up & Shutdown
    • Blending & Mixing
    • Control Strategy
    • Dosage Uniformity
    • Hold Time Studies
    • OSD GMP Checklist
  • Cleaning & Contamination Control
  • Warehouse & Material Handling
    • Warehouse GMP
    • Material Receipt
    • Sampling
    • Status Labelling
    • Storage Conditions
    • Rejected & Returned
    • Reconciliation
    • Controlled Drugs
    • Dispensing
    • FIFO & FEFO
    • Cold Chain
    • Segregation
    • Pest Control
    • Env Monitoring
    • Palletization
    • Damaged Containers
    • Stock Verification
    • Sampling & Weighing Areas
    • Issue to Production
    • Traceability
    • Printed Materials
    • Intermediates
    • Cleaning & Housekeeping
    • Status Tags
    • Warehouse Audit
  • QC Laboratory & Testing
    • Analytical Method Validation
    • Chromatography Systems
    • Dissolution Testing
    • Assay & CU
    • Impurity Profiling
    • Stability & QC
    • OOS Investigations
    • OOT Trending
    • Sample Management
    • Reference Standards
    • Equipment Calibration
    • Instrument Qualification
    • LIMS & Electronic Data
    • Data Integrity
    • Microbiology QC
    • Sterility & Endotoxin
    • Environmental Monitoring
    • QC Documentation
    • Results Review
    • Method Transfer
    • Forced Degradation
    • Compendial Methods
    • Cleaning Verification
    • QC Deviations & CAPA
    • QC Lab Audits
  • Manufacturing & In-Process Control
    • Batch Manufacturing Records
    • Batch Manufacturing Records
    • Line Clearance
    • In-Process Sampling & Testing
    • Yield & Reconciliation
    • Granulation Controls
    • Blending & Mixing
    • Tablet Compression Controls
    • Capsule Filling Controls
    • Coating Process Controls
    • Sterile & Aseptic Processing
    • Filtration & Sterile Filtration
    • Visual Inspection of Parenteral
    • Packaging & Labelling Controls
    • Rework & Reprocessing
    • Hold Time for Bulk & Intermediates
    • Manufacturing Deviations & CAPA
  • Documentation, Training & QMS
    • SOP & Documentation Control
    • Training & Competency Management
    • Change Control & QMS Lifecycle
    • Internal Audits & Self-Inspection
    • Quality Metrics, Risk & Management Review
  • Production SOPs
  • QC Laboratory SOPs
    • Sample Management
    • Analytical Methods
    • HPLC & Chromatography
    • OOS & OOT
    • Data Integrity
    • Documentation
    • Equipment
  • Warehouse & Materials SOPs
    • Material Receipt
    • Sampling
    • Storage
    • Dispensing
    • Rejected & Returned
    • Cold Chain
    • Stock Control
    • Printed Materials
    • Pest & Housekeeping
  • Cleaning & Sanitization SOPs
  • Equipment & Qualification SOPs
  • Documentation & Data Integrity SOPs
  • Deviation/OOS/CAPA SOPs
    • Deviation Management
    • Root Cause
    • CAPA
    • OOS/OOT
    • Complaints
    • Recall
  • Training & Competency SOPs
    • Training System
    • Role-Based Training
    • OJT
    • Refresher Training
    • Competency
  • QA & QMS Governance SOPs
    • Quality Manual
    • Management Review
    • Internal Audit
    • Risk Management
    • Vendors & Outsourcing
  • About Us
  • Privacy Policy & Disclaimer
  • Contact Us

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme